A carregar...
New Medications in the Treatment of Acute Migraine
Migraine is a common disorder affecting 12% of the US population. Use of triptans results in migraine pain relief within 2 hours in 16% to 51% of patients. However, due to their vasoconstrictive properties, triptans are contraindicated in patients with cardiovascular disease, peripheral vascular dis...
Na minha lista:
| Publicado no: | Hosp Pharm |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628551/ https://ncbi.nlm.nih.gov/pubmed/31320771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578719844701 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|